Lv5
1110 积分 2025-05-08 加入
Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile
4个月前
已完结
Mesenchymal Stromal Cell-Derived MMP14 Facilitates Leukemia Progression and Chemotherapy Resistance
4个月前
已关闭
Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients
4个月前
已完结
Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax‐based therapy in the real world: Hokkaido Leukemia Net Study
4个月前
已完结
How I treat patients with AML using azacitidine and venetoclax
5个月前
已完结
Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group
6个月前
已完结
Significant prognostic improvement in elderly patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax: outcomes from a retrospective real-world analysis
6个月前
已完结
Novel therapies for acute myeloid leukemia. Does age still matter?
6个月前
已完结
Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN study
7个月前
已完结
Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy
11个月前
已关闭
皖公网安备34019202002308
